A pioneering study, the Elevated Childhood Lead Interagency Prevalence Study (ECLIPS), has launched in Leeds to screen children aged 1–6 for lead exposure using home-based finger‑prick blood tests, soil and dust sampling, and surveys.
University of Bristol researchers have discovered a VEGF-C gene therapy that protects the kidneys and may prevent serious complications in people with type 1 diabetes.
A UCL-led study shows bioactive nanoparticles can restore blood-brain barrier function and clear amyloid-β in mice, reversing Alzheimer's-like brain changes.
A new NHS screening programme will test babies for hereditary tyrosinemia type 1 at five days old, enabling early treatment to prevent organ damage, liver failure, and other serious complications.
The University of Birmingham leads £1.55m research to assess the long-term effects of vaping on respiratory cells, immunity, and lung microbiome in smokers.
The University of Liverpool researchers create a low-cost, handheld AI-powered blood test to detect Alzheimer's biomarkers, enabling earlier diagnosis and global accessibility.
The NIH has established the Standardized Organoid Modeling Center, aiming to develop reproducible, human-based models using AI and robotics, reducing reliance on animal testing.
A new gene therapy called AMT-130 has shown promising results in slowing the progression of Huntington’s disease, according to the latest results from a global clinical trial.
Lorna Rothery spoke with Victoria Hedley, co-lead of the Rare Disease Research UK Hub, about initiatives aimed at advancing the agenda for rare diseases, as well as the importance of facilitating cross-border collaboration to promote best practices and advance critical research.
A new report starkly reveals the severe and wide-ranging damage that fossil fuels inflict on human health, from the earliest stages of life to old age.
